WEI, Yi,QIN, Luo Heng,COATES, David Andrew,ZHOU, Jingye
申请号：
CR20190124
公开号：
CR20190124A
申请日:
2017.08.04
申请国别(地区):
CR
年份:
2019
代理人:
摘要：
The present invention provides a compound of the following formula, or a salt acceptable in a drug currently defined as N and R1, a method for treating patients with liver diseases, and a process for preparing the compound. Ompounds of the formula (I), or a pharmaceutically acceptable salt there of, where N and R1 are defined here, methods of treating patients for liver disease, and processes for preparing the compounds.La presente invención proporciona compuestos de la Fórmula a continuación, o una sal farmacéuticamente aceptable de estos donde n y R1 se definen en la presente, métodos para tratar pacientes para la enfermedad hepática, y procesos para preparar los compuestos.The present invention provides compounds of the Formula (I), or a pharmaceutically acceptable salt thereof, where n and R1 are defined herein, methods of treating patients for liver disease, and processes for preparing the compounds.
